Sumitomo Life Insurance Co. Has $11.33 Million Stock Position in Procter & Gamble Company (The) $PG

Sumitomo Life Insurance Co. decreased its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 6.2% during the 4th quarter, Holdings Channel reports. The firm owned 79,075 shares of the company’s stock after selling 5,222 shares during the period. Sumitomo Life Insurance Co.’s holdings in Procter & Gamble were worth $11,332,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in PG. Norges Bank acquired a new position in shares of Procter & Gamble during the 4th quarter worth approximately $4,664,783,000. Vanguard Group Inc. increased its position in shares of Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock worth $34,030,358,000 after purchasing an additional 2,829,151 shares during the last quarter. Assenagon Asset Management S.A. increased its position in shares of Procter & Gamble by 100.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company’s stock worth $782,607,000 after purchasing an additional 2,741,924 shares during the last quarter. Amundi increased its position in shares of Procter & Gamble by 26.3% during the 3rd quarter. Amundi now owns 10,682,455 shares of the company’s stock worth $1,606,748,000 after purchasing an additional 2,222,560 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in shares of Procter & Gamble by 272.3% during the 4th quarter. Renaissance Technologies LLC now owns 2,986,061 shares of the company’s stock worth $427,932,000 after purchasing an additional 2,183,911 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE PG opened at $149.47 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The stock has a 50 day moving average of $144.63 and a 200-day moving average of $147.70. The company has a market capitalization of $348.04 billion, a P/E ratio of 21.85, a P/E/G ratio of 6.45 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The company had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same period in the previous year, the company posted $1.54 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a $1.0885 dividend. The ex-dividend date of this dividend was Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s payout ratio is currently 63.60%.

Analyst Ratings Changes

PG has been the topic of several recent analyst reports. Evercore set a $162.00 price target on Procter & Gamble in a research report on Monday, April 27th. Rothschild & Co Redburn lowered their price target on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research report on Monday, April 27th. The Goldman Sachs Group lowered their price target on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 8th. BNP Paribas Exane lowered their price target on Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating on the stock in a research report on Thursday, April 23rd. Finally, Barclays lowered their price target on Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Eleven investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $160.78.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.